Clinical Investigation of Pneumonia Complicating Organophosphate Insecticide Poisoning: Is It Really Aspiration Pneumonia?.
- Author:
Seung Cheol HAN
1
;
Young Ho KO
;
Kyoung Woon JUNG
;
Tag HEO
;
Yong Il MIN
Author Information
1. Department of Emergency Medicine, Chonnam National University, School of Medicine, Gwangju, Korea. minyi@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Organophosphate intoxication;
Aspiration;
Ventilator associated pneumonia
- MeSH:
Anti-Bacterial Agents;
Atropine;
Drainage;
Humans;
Incidence;
Medical Records;
Organophosphate Poisoning;
Pneumonia*;
Pneumonia, Aspiration*;
Pneumonia, Ventilator-Associated;
Poisoning*;
Prevalence;
Radiography, Thoracic;
Respiratory Insufficiency;
Retrospective Studies;
Ventilators, Mechanical
- From:Journal of the Korean Society of Emergency Medicine
2005;16(5):539-546
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Pneumonia is a common complication of organophosphate poisoning and increases the incidence of respiratory failure and the duration of mechanical ventilator support. Therefore, we investigated the clinical characteristics of pneumonia as a complication of organophosphate insecticide poisoning and then determined the factors related to the development of pneumonia. METHODS: A retrospective study was performed on patients with organophosphate insecticide poisoning, who were treated at our hospital with medical records and chest radiograph of patients. From January 1, 2001, to July 31, 2004, eighty five patients were included in this study. RESULTS: 1) Thirty-two (71% of the patients developing pneumonia) patients developed pneumonia later than 48 hours from admission and twenty-five (55.6% of the patients developing pneumonia) patients developed pneumonia later than 48 hours after mechanical ventilatory support. 2) The mean onset of pneumonia resistant to initial empirical antibiotics was 4.8 days from admission, and that of susceptible pneumonia was 3.7 days from admission. 3) Patients with pneumonia as a complication needed larger doses of atropine and more 2-pralidoxime injections, as well as longer mechanical ventilatory support, ICU admission, and total hospital admission. CONCLUSION: Most Pneumonia in organophosphate poisoning patients were nosocomial pneumonia & ventilator-associated pneumonia. Thus, to reduce the incidence of pneumonia complication in organophosphate poisoning patients, Physicians must take measures, such as hand-washing and careful periodic drainage of tubing condensate, etc., to reduce the incidence of nosocomial pneumonia. In selecting empirical antibiotics for pneumonia complicating organophosphate poisoning patients, physicians should take regional prevalence of nosocomial pathogens into consideration. In late-onset ventilator-associated pneumonia, physicians must consider pneumonia caused by organisms resistant to commonly used empirical antibiotics.
